Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **intestinal immune system** is not a single molecule or receptor but rather refers to the largest compartment of the body's overall immune defense. It comprises both innate and adaptive elements distributed throughout specialized anatomical structures in the gut. Key components include epithelial barriers with mucus-secreting goblet cells, antimicrobial peptide-producing Paneth cells, isolated lymphoid follicles, Peyer’s patches, diffuse lymphoid tissue containing macrophages and dendritic cells, mesenteric lymph nodes, intraepithelial T lymphocytes, regulatory T cells, IgA-secreting plasma cells scattered in the lamina propria of the mucosa—and extensive interactions with commensal microbiota[6][8][9]. The intestinal immune apparatus constantly samples dietary antigens and microbial products while maintaining tolerance to harmless substances yet mounting robust responses against pathogens. Disruption of its balance can lead to diseases such as IBD or increased susceptibility to infection. The term "intestinal immune system" thus describes an integrated network rather than any individual therapeutic target. "The intestine represents the largest compartment of the immune system... It is continually exposed to antigens and immunomodulatory agents from diet and commensal microbiota... Intestinal processes are increasingly implicated in controlling disease development elsewhere in body." [8] No drugs directly target the "intestinal immune system" as a whole; drugs may target specific components such as cytokines, receptors, or cells within this system. Mechanisms are diverse and depend on the specific molecular targets within the intestinal immune network. As this is not a single druggable entity but an organ-level concept, there are no specific safety concerns for the "intestinal immune system" as a whole. Because "Intestinal immune system" does not refer to a discrete molecular entity—such as a receptor or enzyme—but instead encompasses many cell types and signaling pathways at an organ-system level, this entry should be marked as incorrect for use as a canonical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal immune system.